公开(公告)号：EP2621291A1

公开(公告)日：2013-08-07

申请号：EP11767814.4

申请日：2011-09-27

申请人： N.V. Nutricia

发明人： GARSSEN, Johan ,  VAN VLIES, Naomi ,  HOGENKAMP, Astrid ,  VAN DE HEIJNING, Hubertus Josephus Maria

IPC分类号： A23L1/29 ,  A23L1/30 ,  A61K31/202 ,  A61P37/00 ,  A61K39/39

CPC分类号： A23D9/05 ,  A23D7/0053 ,  A23L33/115 ,  A23L33/40 ,  A23V2002/00 ,  A61K38/00 ,  A23V2200/304 ,  A23V2200/324 ,  A23V2250/1872 ,  A23V2250/1874

摘要： The present invention relates to a method for enhancing vaccination response and/or preventing infections in a human subject later in life, by administering said human subject a nutritional composition with a specific fat composition having a defined weight ratio of linoleic acid to alpha - linolenic acid when said human subject is an infant with an age between 0 and 36 months.

公开(公告)号：EP2811845B1

公开(公告)日：2015-12-09

申请号：EP12703533.5

申请日：2012-02-10

申请人： N.V. Nutricia

发明人： GARSSEN, Johan ,  HOGENKAMP, Astrid ,  VAN ESCH, Elisabeth Catharina Adriana Maria ,  KNIPPELS, Leon Matthieu Johannes

IPC分类号： A23C9/20

CPC分类号： A61K31/702 ,  A23C9/206 ,  A23L33/21 ,  A23L33/40 ,  A23V2002/00 ,  A23V2200/324 ,  A23V2250/284

公开(公告)号：EP4346443A1

公开(公告)日：2024-04-10

申请号：EP22730911.9

申请日：2022-05-31

申请人： N.V. Nutricia

发明人： GENUNEIT, Jon ,  SIZIBA, Linda ,  ROTHENBACHER, Dietrich ,  BUCHENAUER, Lisa ,  MANK, Marko ,  STAHL, Bernd ,  WIERTSEMA, Selma ,  VAN SADELHOFF, Joris Henricus Johannes ,  WITTE, Gerrit ,  HOGENKAMP, Astrid

IPC分类号： A23L33/00 ,  A23L33/175 ,  A61K31/195 ,  A61P11/06 ,  A61P11/08 ,  A61P17/00

公开(公告)号：EP2811845A1

公开(公告)日：2014-12-17

申请号：EP12703533.5

申请日：2012-02-10

申请人： N.V. Nutricia

发明人： GARSSEN, Johan ,  HOGENKAMP, Astrid ,  VAN ESCH, Elisabeth Catharina Adriana Maria ,  KNIPPELS, Leon Matthieu Johannes

IPC分类号： A23L1/29 ,  A23L1/308 ,  A61K31/702 ,  A61K35/20

CPC分类号： A61K31/702 ,  A23C9/206 ,  A23L33/21 ,  A23L33/40 ,  A23V2002/00 ,  A23V2200/324 ,  A23V2250/284

摘要： There is provided compositions and methods for enhancing an immune system and/or preventing an immune system related disorder in a mammalian subject, the composition comprising a non-digestible oligosaccharide which is to be administered to a female who is breast-feeding the mammalian subject.